Cargando…
Outcomes of Roux-en-Y gastric bypass surgery for severely obese patients with type 1 diabetes: a case series report
Roux-en-Y gastric bypass surgery (RYGB) reverses type 2 diabetes (DM2) in approximately 83% of patients with morbid or severe obesity. This procedure has been performed in small numbers of severely obese patients with type 1 diabetes (DM1), but the impact on glycemic control and insulin requirement...
Autores principales: | Mendez, Carlos E, Tanenberg, Robert J, Pories, Walter |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3047955/ https://www.ncbi.nlm.nih.gov/pubmed/21437096 |
Ejemplares similares
-
Bacteria with potential: Improving outcomes through probiotic use following Roux‐en‐Y gastric bypass
por: Nowicki, Kylie N., et al.
Publicado: (2022) -
Time course metabolome of Roux-en-Y gastric bypass confirms correlation between leptin, body weight and the microbiome
por: Seridi, Loqmane, et al.
Publicado: (2018) -
Pregnancy following gastric bypass surgery (Roux-en-Y) for morbid obesity
por: Anasiudu, R, et al.
Publicado: (2011) -
Laparoscopic Roux-en-Y Gastric Bypass for Morbid Obesity
por: Nguyen, Ninh T., et al.
Publicado: (1999) -
Laparoscopic Roux en Y gastric bypass in the super obese
por: Aly, Ahmad, et al.
Publicado: (2020)